APA

Groenendijk F. H., Taal W., Dubbink H. J., Haarloo C. R., Kouwenhoven M. C., van den Bent M. J., Kros J. M. & Dinjens W. N. M. (20110505). MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation. : Journal of neuro-oncology.

Chicago

Groenendijk Floris H, Taal Walter, Dubbink Hendrikus J, Haarloo Cathleen R, Kouwenhoven Mathilde C, van den Bent Martin J, Kros Johan M and Dinjens Winand N M. 20110505. MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation. : Journal of neuro-oncology.

Harvard

Groenendijk F. H., Taal W., Dubbink H. J., Haarloo C. R., Kouwenhoven M. C., van den Bent M. J., Kros J. M. and Dinjens W. N. M. (20110505). MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation. : Journal of neuro-oncology.

MLA

Groenendijk Floris H, Taal Walter, Dubbink Hendrikus J, Haarloo Cathleen R, Kouwenhoven Mathilde C, van den Bent Martin J, Kros Johan M and Dinjens Winand N M. MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation. : Journal of neuro-oncology. 20110505.